Why Avestria Invested in this Genetic Health Startup

In this series, we explain why we invested in our current portfolio companies. In the process, we hope to highlight the white spaces in women’s health and the life sciences — as well as the people, products, and companies working to fill those gaps. The name “Under the Microscope” refers both to our extensive due diligence process and our investment focus on healthcare and the life sciences.

On February 12, 2020, at the UN Headquarters in New York City, Lisa Alderson addressed the United Nations General Assembly at the 5th International Day of Women and Girls in Science Assembly. Lisa is no stranger to advocating for women in the sciences, but, despite her parallel interests with Avestria, we didn’t get a chance to work with Lisa until 2020, when we invested in her life science company, Genome Medical. …


Why Avestria Invested in this Nasal Swab Collection-Focused Startup

In this series, we explain why we invested in our current portfolio companies. In the process, we hope to highlight the white spaces in women’s health and the life sciences — as well as the people, products, and companies working to fill those gaps. The name “Under the Microscope” refers both to our extensive due diligence process and our investment focus on healthcare and the life sciences.

In December, the New York Times ran a feature: “Nobody Sees Us: Testing Lab Workers Strain Under the Demand.” …


Why Avestria Invested in this Fetal Heath-Focused Startup

In this series, we explain why we invested in our current portfolio companies. In the process, we hope to highlight the white spaces in women’s health and the life sciences — as well as the people, products, and companies working to fill those gaps. The name “Under the Microscope” refers both to our extensive due diligence process and our investment focus on healthcare and the life sciences.

In December, the U.S Department of Health and Human Services outlined its maternal health goals for the next few years: reducing maternal mortality rate by 50%, reducing low-risk Cesarean delivery rate by 25%, and achieving blood pressure control in 80% of reproductive-age women with hypertension. …


Why Avestria Invested in this Vaginal Dryness-Focused Startup

In this series, we explain why we invested in our current portfolio companies. In the process, we hope to highlight the white spaces in women’s health and the life sciences — as well as the people, products, and companies working to fill those gaps. The name “Under the Microscope” refers both to our extensive due diligence process and our investment focus on healthcare and the life sciences.

1.3 million women become menopausal every year — and that number is only going to grow. A 2015 study estimates that 1.2 billion women across the world will be menopausal or post-menopausal by the year 2030. …


Why Avestria Invested in this UTI-Focused Startup

In this series, we explain why we invested in our current portfolio companies. In the process, we hope to highlight the white spaces in women’s health and the life sciences — as well as the people, products, and companies working to fill those gaps. The name “Under the Microscope” refers both to our extensive due diligence process and our investment focus on healthcare and the life sciences.

“I’ve been there — stuck in the awful cycle of UTIs. In 2014, I had 8 UTIs,” Uqora’s Co-Founder and CEO Jenna Ryan writes on Uqora’s “Our Story” webpage.

Jenna is not alone. Defined as an infection in any part of an individual’s urinary system — which includes kidneys, ureters, bladder and urethra —urinary tract infections (UTIs) were the most common outpatient infection in 2019 and the second most common infection (behind the common cold) in the U.S


Why Avestria Invested in this Physician Education Startup

In this series, we explain why we invested in our current portfolio companies. In the process, we hope to highlight the white spaces in women’s health and the life sciences — as well as the people, products, and companies working to fill those gaps. The name “Under the Microscope” refers both to our extensive due diligence process and our investment focus on healthcare and the life sciences.

Medical information doubles every 73 days. That doubling time has only increased in recent years: from 50 years in 1950, to 7 years in 1980, and down to 3.5 years in 2010. To put in context, students who graduated medical school in 2020 will have experienced four doublings of knowledge during seven years of training; what they learned in their first three years is, by the end of 2020, only about 6% of total medical knowledge. …


Why Avestria Invested in this PPH-Focused Startup

In this series, we explain why we invested in our current portfolio companies. In the process, we hope to highlight the white spaces in women’s health and the life sciences — as well as the people, products, and companies working to fill those gaps. The name “Under the Microscope” refers both to our extensive due diligence process and our investment focus on healthcare and the life sciences.

While it may seem unbelievable, the United States has the worst maternal mortality rate in the developed world: 17.4 deaths per 100,000 live births. In fact, the U.S is the only developed nation where the maternal death rate has been steadily rising, more than doubling over the past two decades and increasing 80% alone from 1990 to 2015. Women of color are often affected the most: black women have a maternal death rate of 37.1 deaths per 100,000 live births compared to 14.7 for white women and 11.8 …

About

Avestria Ventures

Investing in early-stage women’s health and female-led life sciences companies.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store